SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-14-054778
Filing Date
2014-02-14
Accepted
2014-02-14 16:19:56
Documents
1
Group Members
ANDERS HOVEBRYAN ROBERTSVHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d676712dsc13ga.htm SC 13G/A 122895
  Complete submission text file 0001193125-14-054778.txt   124540
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81457 | Film No.: 14616764
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94306
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94306 650-561-9580
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A